HKEX Stock Code: 01093
English
|
繁體
|
简体
Home
About Us
Products
News
Competence
Investor Relations
Contact Us
Corporate Profile
Corporate Information
Corporate Culture
Board of Directors
Corporate Governance
Products Overview
Finished Drugs
Bulk Drugs
Press Releases
Strategies
Quality
Research and Development
IR Overview
Financial Reports
CSR Reports
Announcements & Notices
Circulars
Returns on Share Capital
Notice(s) of Replacement of Lost Share Certificates
Financial Calendar
Financial Summary
IR Contacts
News
Press Releases
Home
>
News
> Press Releases
Press Releases
2020
2019
2018
2017
2016
Aug
29
Press Release (Chinese Version)
Aug
19
CSPC Pharmaceutical Announces 2019 Interim Results, Profit Attributable to Shareholders Increased 24.8% to RMB1,878 Million, Innovative Drug Business Continued to Deliver Strong Growth, R&D Investment Increased Significantly
Mar
18
CSPC Pharmaceutical Announces 2018 Annual Results, Profit Attributable to Shareholders Increased 31.9% to HK$3,655 Million, Innovative Drug Business Continued to Deliver Strong Growth R&D Deployment Further Improved